Drug General Information (ID: D1787)
  Drug Name
Fluorescein
  Drug Type Small molecule
  Drug Synonymous
Ful-Glo; Fluoreseptic; 41935-48-2; NSC5070
    Click to Show/Hide
  Disease Class 1F00: Herpes simplex infection
  Therapeutic Class Diagnostic Agents
  Structure Could Not Find 2D Structure
3D Structure 2D Structure
  Formula C20H12O5
  InChI 1S/C20H12O5/c21-11-5-7-15-17(9-11)24-18-10-12(22)6-8-16(18)20(15)14-4-2-1-3-13(14)19(23)25-20/h1-10,21-22H
  InChIKey GNBHRKFJIUUOQI-UHFFFAOYSA-N
  Canonical SMILES C1=CC=C2C(=C1)C(=O)OC23C4=C(C=C(C=C4)O)OC5=C3C=CC(=C5)O
  External Link
Pubchem ID 16850
CAS Number CAS 2321-07-5
CHEBI ID CHEBI:31624
TTD ID D06TJJ
VARIDT ID DR00547

Drug-Drug Interaction Network
  Sunburst Graph
AM006  Pharmacodynamic additive effects
BM048  Increased risk of angioedema/anaphylactoid reactions
  Relation Graph
 Full list of drugs interacting with Fluorescein
      Pharmacodynamic additive effects
   Increased risk of angioedema/anaphylactoid reactions Drug Num:  28
Drug ID
 
Drug Name
Formula Pubchem ID Severity Level Interaction Detail REF
D0117
 
Atenolol
 
C14H22N2O3
 
2249 
Moderate    Inter Info   
[1], [2], [3]
D0173
 
Betaxolol
 
C18H29NO3
 
2369 
Moderate    Inter Info   
[1], [2], [3]
D0174
 
Betaxolol (ophthalmic)
 
C18H29NO3
 
2369 
Moderate    Inter Info   
[1], [2], [3]
D0188
 
Bisoprolol
 
C18H31NO4
 
2405 
Moderate    Inter Info   
[1], [2], [3]
D0266
 
Carteolol (ophthalmic)
 
C16H24N2O3
 
2583 
Moderate    Inter Info   
[1], [2], [3]
D0567
 
Enalapril
 
C20H28N2O5
 
5388962 
Moderate    Inter Info   
[1], [2], [3]
D0602
 
Esmolol
 
C16H25NO4
 
59768 
Moderate    Inter Info   
[1], [2], [3]
D0010
 
Acebutolol
 
C18H28N2O4
 
1978 
Moderate    Inter Info   
[1], [2], [3]
D0254
 
Captopril
 
C9H15NO3S
 
44093 
Moderate    Inter Info   
[1], [2], [3]
D0267
 
Carvedilol
 
C24H26N2O4
 
2585 
Moderate    Inter Info   
[1], [2], [3]
D0915
 
Levobunolol (ophthalmic)
 
C17H25NO3
 
39468 
Moderate    Inter Info   
[1], [2], [3]
D0938
 
Lisinopril
 
C21H31N3O5
 
5362119 
Moderate    Inter Info   
[1], [2], [3]
D1045
 
Metipranolol (ophthalmic)
 
C17H27NO4
 
31477 
Moderate    Inter Info   
[1], [2], [3]
D1098
 
Nadolol
 
C17H27NO4
 
39147 
Moderate    Inter Info   
[1], [2], [3]
D1114
 
Nebivolol
 
C22H25F2NO4
 
71301 
Moderate    Inter Info   
[1], [2], [3]
D1256
 
Perindopril
 
C19H32N2O5
 
107807 
Moderate    Inter Info   
[1], [2], [3]
D1293
 
Pindolol
 
C14H20N2O2
 
4828 
Moderate    Inter Info   
[1], [2], [3]
D1369
 
Quinapril
 
C25H30N2O5
 
54892 
Moderate    Inter Info   
[1], [2], [3]
D0695
 
Fosinopril
 
C30H46NO7P
 
55891 
Moderate    Inter Info   
[1], [2], [3]
D0884
 
Labetalol
 
C19H24N2O3
 
3869 
Moderate    Inter Info   
[1], [2], [3]
D1049
 
Metoprolol
 
C15H25NO3
 
4171 
Moderate    Inter Info   
[1], [2], [3]
D1082
 
Moexipril
 
C27H34N2O7
 
91270 
Moderate    Inter Info   
[1], [2], [3]
D1357
 
Propranolol
 
C16H21NO2
 
4946 
Moderate    Inter Info   
[1], [2], [3]
D1379
 
Ramipril
 
C23H32N2O5
 
5362129 
Moderate    Inter Info   
[1], [2], [3]
D1498
 
Sotalol
 
C12H20N2O3S
 
5253 
Moderate    Inter Info   
[1], [2], [3]
D1585
 
Timolol
 
C13H24N4O3S
 
33624 
Moderate    Inter Info   
[1], [2], [3]
D1586
 
Timolol (ophthalmic)
 
C13H24N4O3S
 
33624 
Moderate    Inter Info   
[1], [2], [3]
D1618
 
Trandolapril
 
C24H34N2O5
 
5484727 
Moderate    Inter Info   
[1], [2], [3]
References
1 Ray K, Dorman S, Watson R "Severe hyperkalaemia due to the concomitant use of salt substitutes and ACE inhibitors in hypertension: a potentially life threatening interaction." J Hum Hypertens 13 (1999): 717-20. [PMID: 10516744]
2 Product Information. Vasotec (enalapril). Merck &amp Co, Inc, West Point, PA.
3 Product Information. AK-Fluor (fluorescein). Akorn Inc, Buffalo Grove, IL.